BlackRock Institutional Trust’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
Other funds holding ARNA
BFA
CCM
SAM
AC
BlackRock Institutional Trust's ARNA Position: Q4 2016 in Review
BlackRock Institutional Trust increased its Arena Pharmaceuticals Inc (ARNA) stake by 1.5% in Q4 2016, buying an estimated $143K and bringing the position to 623,889 shares worth $8.86M. The position accounts for ﹤0.01% of the portfolio, ranked #2462.
BlackRock Institutional Trust first reported a position in ARNA in Q2 2013 and has held it in 15 quarters since. The position peaked at $47.9M in Q2 2013. 128 funds tracked by Wall St. Rank hold ARNA as of Q4 2016.
- BlackRock Institutional Trust held 623,889 shares of Arena Pharmaceuticals Inc worth $8.86M as of Q4 2016.
- BlackRock Institutional Trust bought 9,224 Arena Pharmaceuticals Inc shares in Q4 2016, an estimated $143K.
- Arena Pharmaceuticals Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2462 holding.
- BlackRock Institutional Trust first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and has held it in 15 quarters since.
- BlackRock Institutional Trust's Arena Pharmaceuticals Inc position peaked at $47.9M in Q2 2013.
- 128 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.